ben vision research facebook   Ben Vision research on Goggle+   ben vision research onlinkedin   ben vision research on angels list
Dr. Karan R. Gregg Aggarwala Dr. Karan R. Gregg Aggarwala
OD (NIH Equivalent), MS, PhD, FAAO
Cell: 347-949-0411

With formal training in clinical ophthalmic sciences, visual psychophysics, advanced optics of the eye, stimuli for accommodation, neuroscience of the retina, neurology of eye movements, ultrasound biophysics of the eye, visual development of children and learning disorders, nutrition and biochemistry of the eye, and public health as applied to optometry and ophthalmology, Dr. Aggarwala leads the Ben Vision Research team.

Dr. Karan R. Aggarwala received a National Research Service Award from the National Institutes of Health, Bethesda, MD, for his research on behavioural neuroscience of eye focusing at the State University of New York, College of Optometry. He is a Fellow of the American Academy of Optometry since December, 1999.
Although the ideas, drawings, documents and prototypes that fuel Ben Vision Research have been fermenting in his closets and on his collaborators' desks since 1995, active work began in 2006 with the filing of a US patent application that was approved by the Patent and Trademark Office in 2011.

Karan's favorite pastime is reading & writing poetry while munching popcorn and drinking ginger-ale, especially in Central Park & in dimly illuminated New York City establishments.

Dr. Aggarwala works with a team of intellectual property attorneys to file patents, trademarks and copyrights. He interfaces with scientists, eye doctors, public health professionals, prototyping robotics laboratories, manufacturers, distributors, and service engineers. His colleagues in clinical optometry and ophthalmology, and scientists that conduct research in vision science, regard him as a valuable contributor to advancing eye care diagnostics and ocular public health.

Non-profits, pharmaceutical consulting firms, and consumer advocacy groups have been pleased to receive Dr. Aggarwala's numerous contributions on general medicine, ophthalmic research, consumer rights, education, and environmental issues.

Dr. Aggarwala designed and taught for 5 semesters a curriculum for business school and science undergraduates affiliated with North Dakota State University based on philosophies of personal development, ethical corporate governance, creative thinking, and social responsibility.
Dr. Robert Ritch Dr. Robert Ritch
Vice-President, Ocular Diagnostic and Enhancement Products

Dr. Robert Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director Emeritus and Chief of Glaucoma Services at the New York Eye & Ear Infirmary, New York City and Professor of Ophthalmology at The New York Medical College, Valhalla, New York. He has devoted his career to broadening our understanding of the underlying etiologies and mechanisms of glaucoma and innovation in its medical, laser, and surgical treatment. When still a fellow in 1978, he performed the first laser iridotomy in New York and initiated the first course on laser treatment of glaucoma at the American Academy of Ophthalmology. He developed argon laser peripheral iridoplasty for the treatment of angle closure more complicated than pupillary block, which was instrumental in dealing with angle closure in East Asia, and taught on the diagnosis and treatment of angle closure around the world. His other major interests throughout his career have been pigment dispersion syndrome, exfoliation syndrome, and normal-tension glaucoma, to whch he has made seminal contributions.

Dr. Ritch has co-authored or edited nine textbooks and over 1600 medical and scientific papers, book chapters, articles and abstracts. He has presented nearly 700 lectures worldwide, including 40 named lectures and has received over 40 awards and medals.

Dr. Ritch has been President of the Ophthalmic Laser Surgical Society, the New York Glaucoma Society, the Section on Ophthalmology of the New York Academy of Medicine, and the New York Society for Clinical Ophthalmology. He serves on numerous medical and scientific advisory and editorial boards and is a member of the Glaucoma Research Society, the Steering Committee of the World Glaucoma Association, and the Board of Directors of the Pan-American Association of Ophthalmology.

Dr. Ritch has received the Heed Ophthalmic Foundation Ophthalmologist of the Year award (1996), the Gold Medal of Merit and Honor from the Greek Glaucoma Society, and the Ophthalmology Times Achievement in Ophthalmology Award (1998). In 1999, he was one of the winners of the Louis Rudin Award for research in ophthalmology. In 2000, he received the Jesse H. Neal Award for Editorial Achievement. In 2002, he was appointed to the Advisory Committee to the Board of Directors of the International Council of Ophthalmology and was elected Chairman of the Committee in 2009 and appointed to the Board of Directors of the International Council. He was elected to the Board of Trustees of the Association for Research in Vision and Ophthalmology and served as Vice-President in 2006-2007. His awards since 2006 include the Albion O. Bernstein, MD Award of the Medical Society of the State of New York for outstanding contributions to medicine, the American Academy of Ophthalmology Lifetime Achievement Honor Award, the Leadership in Education in Ophthalmology (LEO) Award, the Dean's Distinguished Research Award from the New York Medical College, The Glaucoma Foundation Award for Innovation and Excellence in Glaucoma, the TKC Liu Memorial Award for Leadership in Ophthalmology, the Ronald F. Lowe Gold Medal of the Australia-NewZealand Ophthalmology Society, the Dominick Purpura Distinguished Alumnus Annual Award from Albert Einstein College of Medicine, the ARVO Distinguished Service Award, ARVO Gold Fellowship, the HRH Prince Abdulaziz Al-Saud Prevention of Blindness Award, the Ahti Tarkkanen Medal (Finland), the Jose Rizal International Medal, the El-Maghraby International Achievement Award, the inaugural Asia-Pacific Glaucoma Society International Achievement Award, the World Glaucoma Association Recognition Award, and the Moacyr Alvaro Gold Medal (Brazil). In 2012, he was elected to Academia Ophthalmologica Internationalis. He was the American Glaucoma Society Guest of Honor (2013).

Dr. Ritch has co-authored or edited nine textbooks and over 1600 medical and scientific papers, book chapters, articles and abstracts. He has presented nearly 700 lectures worldwide, including 36 named lectures. In 1985, he founded the Glaucoma Foundation and has served as Secretary, Medical Director, and Chairman of the Scientific Advisory Board. In 1994, he initiated the annual Optic Nerve Rescue and Regeneration Think Tank, which has attracted numerous successful researchers from other fields into glaucoma research. He also co-founded the New York Glaucoma Research Institute, a not-for-profit foundation to sponsor clinical research in glaucoma, the Internet newsgroup, the New York Glaucoma Support and Education Group, and the World Glaucoma Patient Association. He was one of the three organizers of the first annual World Glaucoma Day in 2008. He was co-founder of the Ophthalmic Laser Surgical Society, the New York Glaucoma Society, and the Lindberg Society, an international organization dedicated to the eradication of exfoliation syndrome; the ARVO Host-a-Research Program, the ARVO U.S.-Russia Ophthalmology Task Force, the Von Graefe Society, an international organization dedicated to the study of risk factors for glaucoma other than intraocular pressure.

Dr. Ritch has trained over 140 clinical and research fellows, many of whom occupy academic positions worldwide. The international training program that he established at the New York Eye and Ear Infirmary has hosted over 60 International Council of Ophthalmology fellows and more than 100 observers from over 40 countries. He has worked and lectured extensively at the international level and has organized many symposia and conferences both in the United States and abroad. He has dedicated much of his time internationally over the last 30 years, and has organized conferences and symposia, trained over 80 fellows, ICO fellows, and observers from Asia, helped to establish residency and teaching programs and has made fundamental contributions to the modernization of ophthalmology in Thailand, Malaysia, the Philippines, Laos, Myanmar and other countries in Asia, and in Latin America. There are Asian, Brazilian, and International Ritch Fellows Societies.

Dr. Mark Packer Mark Packer, MD
Chief Surgical Advisor

Dr. Mark Packer is an experienced ophthalmologist with a distinguished career in managing a wide range of clinical and surgical conditions of the eye and their associated systemic disorders. He is recognized internationally as a leader in cataract surgery and for his original research which has established groundbreaking, innovative technologies. He has served as the Chairman of the Cataract Clinical Committee of the American Society of Cataract and Refractive Surgery; and he is one of six surgeons chosen by the American Academy of Ophthalmology to author the current Preferred Practice Pattern for Cataract. Elected to membership in the prestigious International Intra Ocular Implant Club in 2005, he is currently Clinical Associate Professor of Ophthalmology at Oregon Health & Sciences University and the Director of the Bowie Vision Institute for Ophthalmic Research.

Dr. Packer has over one hundred peer-reviewed scientific publications, including "Evaluation of the Aspheric Tecnis Multifocal Intraocular Lens" in American Journal of Ophthalmology, "Effect of Intraoperative Aberrometry on the Rate of Postoperative Enhancement" in Journal of Cataract and Refractive Surgery, and "Aspheric Intraocular Lens Selection Based on Corneal Wavefront" in Journal of Refractive Surgery. He has edited textbooks on cataract and refractive lens surgery, written hundreds of book chapters, and served as the editor of the annual Cataract and IOL issue of Current Opinion in Ophthalmology.
Dr. Packer works extensively with leaders in the ophthalmic industry on the development of innovative technology. He has served as Principal Investigator or Medical Monitor in over fifty clinical trial protocols leading to FDA approvals. He is widely sought after as an independent consultant by established opthalmic companies and start-ups that serve the world population in numerous ways.
Dr. Jeffrey Cooper Dr. Jeffrey Cooper
Assistant Vice-President, Ocular Biometry

As Assistant Vice-President of the Ocular Biometry component of Ben Vision Research, Dr. Jeffrey Cooper (OD, FAAO, FCOVD) brings to our team vast experience in therapy for binocular eye muscle anomalies. Dr. Cooper is a leader in clinical management of amblyopia (lazy eye) and convergence insufficiency and he lectures frequently across 3 continents.

Dr. Cooper has developed and produced software for assessment of binocular function and for training binocular coordination. He is a leader in the assessment of visual stress associated with tasks that involve depth perception, and has counseled athletes and airline pilots. Strabismus surgeons in New York City rely on the functional evaluations of ocular alignment arising from his clinical team on Park Avenue for patients with eye muscle paralysis.

Dr. Cooper actively participates in conferences involving management of neurological eye disorders. His affiliation with Ben Vision Research began in 2011 after the award of a US Patent to Dr. Aggarwala for an Interactive Subjective Refraction Apparatus.

Dr. Cooper will represent the company at major eye care conferences and will lead the team for strategic decisions regarding clinical needs of optometrists and ophthalmologists.
Warren Ward Warren Ward
Manufacturing Partner

Chief Technologist at Ward Electro-Optics, Gallatin, MO, Warren Ward brings to Ben Vision Research a high level of expertise and commitment to prototype and manufacture eye care technology, visual neuroscience, motion control electronics and advanced optical and electrical applications.

Warren has a distinguished track record of designing, manufacturing, and servicing precision eye movement tracking equipment and visual stimulus presentation optics sold to universities and aircraft pilot-training programs in the US, Europe, and Japan.

Mr. Ward has been recommended highly for his creativity, leadership, and domain expertise by his university research clients and by Home Depot. He received his training in engineering at San Diego State University and was President of Fourward Optical Technologies prior to his present engagements
Joseph F. Daniels J.D. Houvener

J.D. Houvener is a Registered USPTO Patent Attorney who has a strong interest in helping entrepreneurs and businesses thrive. J.D. leverages his technical background in engineering and experience in the aerospace industry to provide businesses a unique perspective to their patent needs. J.D. works with clients that are serious about investing in their intellectual assets and provides counsel on how to capitalize their patent in the market.

His background in business and experience as an engineer and patent attorney empowers him to clearly communicate to a broad range of clients about their immediate and long-term needs for patenting in order to protect assets, leverage opportunities, and limit liabilities. Some key areas of the patent prosecution practice are: patentability searches, patent applications, office actions, infringement opinions, post-grant actions and consultation on patent strategy and portfolio management.
Gerard F. Diebner Gerard F. Diebner

Gerard F. Diebner has over 25 years of experience in the field of patent law. His practice concentrates in the areas of pharmaceuticals, biotechnology, chemistry, medical devices, cosmetics, agriculture, veterinary products, pollution control, clean energy and business methods.

Mr. Diebner has extensive trial experience both before the Federal District Courts and the ITC. He also handles patent issues concerning mergers and acquisitions and due diligence searches, and provides general intellectual property corporate advice. He drafts and prosecutes patent applications before the U.S. Patent and Trademark Office and has substantial experience with interference practice. Mr. Diebner works with individual inventors, start-up corporations in emerging growth industries and established multi-national companies.

Mr. Diebner was involved with one of the first biotechnology lawsuits ever brought and was successful in one of the longest biotechnology cases tried to a jury. Mr. Diebner was also involved with Novo Nordisk's successful litigation against Genentech concerning human growth hormone and with representing Merck against Searle in a patent interference, where it was held that Merck, not Searle, was the first to invent VIOXX. Mr. Diebner was lead trial counsel for Proveris Scientific Corp. in Proveris v. Innovasystems, which established that the use of a patent laboratory instrument for the purpose of obtaining FDA approval for a drug product did not fall within the sale harbor provision of 35 U.S.C. ยง271(e)(1).
Ben Vision Research, Inc. 1410 York Avenue Suite 6E New York, NY 10021 Phone: (212) 717-1015

© 2018 All content is the property of Ben Vision Research, Inc. ™ & assoc. vendors. | DISCLAIMER | HIPAA | SiteMap
Website Powered and Developed by